• Home
  • Health & Wellness
  • Disclaimer
    • Terms of Use
    • Privacy Policy
    • DMCA Notice
Podcast
  • Home
  • Health & Wellness
  • Disclaimer
    • Terms of Use
    • Privacy Policy
    • DMCA Notice
24/7 Health News
No Result
View All Result
Home Article

Malaria vaccine: the road has been long and tortuous, but we’re getting there

September 14, 2022
in Article
0
Malaria vaccine: the road has been long and tortuous, but we’re getting there

A vaccine candidate, called R21, has been shown to be up to 80% effective at preventing malaria in young children, according to the latest trial results.

This follows from a study published in 2021 from the same team at Oxford University which showed that the three-dose vaccine was up to 77% effective at preventing malaria. Their latest study shows that a booster, given a year later, maintains the levels of protection at 70% to 80%, suggesting that long-term protection is possible.

The Oxford researchers told the BBC that their vaccine can be made for “a few dollars”, and they have a deal to manufacture over 100 million doses a year.

However, there is still a large hurdle to overcome. Phase 3 clinical trials – the final phase of testing in humans before regulatory approval can be sought – are yet to be conducted.

A long road with many dead ends

The quest to develop a malaria vaccine began almost 100 years ago. As early as the 1940s, attempts to protect against malaria infection by injecting inactivated parasites were conducted in animals and in humans. Since then, relentless efforts continued until advances in biochemistry and molecular biology made it possible for scientists to isolate proteins from the plasmodium parasite that causes malaria to use in the vaccine and make them in a lab.

These proteins were predicted to induce better immunity against infection. Although the parasite has the same proteins, their accessibility and exposure to the immune system can be less effective at inducing a response. Also, using inactivated whole parasites bring other potential problems, such as toxicity and even the re-activation of the parasite causing an active infection.

These modern techniques led to the development in the late 1980s of the SPf66 vaccine that comprised several synthetic molecules of the parasite that were known to be recognised by the immune system in humans. The vaccine, which was developed in Colombia, was trialled in various countries in South America, achieving an efficacy of 35% to 60%. But when testing was extended to other continents, efficacy was lower: 8% to 30% in Africa and no protection at all in Asia.

Though disappointing, these findings were encouraging because some immunity was achieved, showing that a vaccine against the biggest killer in the tropical world is possible.

Many vaccines were designed since using different components of the parasite and tested in clinical trials, including RTS,S which became the first licensed anti-malaria vaccine. It contains part of a major protein found on the surface of the parasite that starts the infection: the so-called sporozoite stage (see graphic below) that infects the liver.

Stages of malaria.
Stages of malaria.
N.Vinoth Narasingam/Shutterstock

RTS,S was widely tested in Africa, reaching levels of protection of around 40% that decreased with time. It is based on the same parasite molecule used in R21.

Achieving high levels of protection against malaria has proven very difficult. Even in those cases when promising results were obtained, the effectiveness decreased dramatically when testing the vaccines more widely.

Another issue is that, very often, immunity gained from these candidate vaccines fell over time. Long-term immunity is important because the risk of infection continues throughout life, particularly in areas where transmission is high.

Why it’s been so hard to find an effective vaccine

Advances in gene sequencing in the past few decades have allowed us to analyse the malaria-causing parasite’s genome.

The sequencing of samples from patients from around the world changed our understanding of the parasite and the disease. It became clear that there isn’t one parasite but many genetically distinct strains. And this diversity is reflected in the components of the parasite, including those used in the vaccines.

Because the vaccines were developed with strains of parasites kept in laboratories, the identity of the vaccine is restricted to that particular parasite and, as a result, the immune system will be trained to recognise similar parasites but not necessarily other genetically different strains. This problem is increased by the complexity of the life cycle of these parasites and the differences in the dynamics of the infection in different regions of the world.

In Africa, the transmission of the disease is high and, as a result, it is common that people get infected with several genetically different parasites. So if the vaccine is effective against limited genetic versions, then some will be eliminated by the immune system but not others. This is a major problem in developing an effective vaccine against malaria because it makes it difficult to eliminate the parasite from the body. This might also be at least part of the reason most vaccines tested so far have low protection which wanes over time.

The high level of protection obtained with R21, the malaria vaccine developed by scientists at Oxford University, is really promising. The protection it gives will be followed closely with great expectations to find out whether it can be sustained in the long term. It will also be very important to test it in different parts of the world to find out if it gives wide protection. And, finally, it will also be helpful to know whether it can protect older children and adults and become a general preventive tool against malaria.

The Conversation

Alena Pance does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

ShareTweetSharePin
Previous Post

Why the body positivity movement risks turning toxic

Next Post

Stroke: young people can have them too – here’s how to know if you’re at risk and what to look out for

Next Post
Stroke: young people can have them too – here’s how to know if you’re at risk and what to look out for

Stroke: young people can have them too – here's how to know if you're at risk and what to look out for

Most Read

What causes stuttering? A speech pathology researcher explains the science and the misconceptions around this speech disorder

What causes stuttering? A speech pathology researcher explains the science and the misconceptions around this speech disorder

December 15, 2022
morning back pain

Morning Again Ache Trigger Is Not the Mattress

October 11, 2021
lower back pain relief exercises

5 decrease again ache aid workouts

October 11, 2021
3 years after legalization, we have shockingly little information about how it changed cannabis use and health harms

3 years after legalization, we have shockingly little information about how it changed cannabis use and health harms

October 15, 2021
Nasal vaccines promise to stop the COVID-19 virus before it gets to the lungs – an immunologist explains how they work

Nasal vaccines promise to stop the COVID-19 virus before it gets to the lungs – an immunologist explains how they work

December 14, 2022
bleeding in gum

When The Bleeding in gum Is Severe ?

October 11, 2021
Good Night Sleep

6 Causes of Good Evening Sleep

October 11, 2021

COVID vaccines: how one can pace up rollout in poorer international locations

October 5, 2021
Ten small changes you can make today to prevent weight gain

Ten small changes you can make today to prevent weight gain

October 12, 2021
Support and collaboration with health-care providers can help people make health decisions

Support and collaboration with health-care providers can help people make health decisions

December 16, 2021
Greece to make COVID vaccines mandatory for over-60s, but do vaccine mandates work?

Greece to make COVID vaccines mandatory for over-60s, but do vaccine mandates work?

December 1, 2021

Multiple sclerosis: the link with earlier infection just got stronger – new study

October 12, 2021
News of war can impact your mental health — here’s how to cope

Binge-eating disorder is more common than many realise, yet it’s rarely discussed – here’s what you need to know

December 2, 2022
Nurses’ attitudes toward COVID-19 vaccination for their children are highly influenced by partisanship, a new study finds

Nurses’ attitudes toward COVID-19 vaccination for their children are highly influenced by partisanship, a new study finds

December 2, 2022
Kick up your heels – ballroom dancing offers benefits to the aging brain and could help stave off dementia

Kick up your heels – ballroom dancing offers benefits to the aging brain and could help stave off dementia

January 3, 2023
How hot is too hot for the human body? Our lab found heat + humidity gets dangerous faster than many people realize

How hot is too hot for the human body? Our lab found heat + humidity gets dangerous faster than many people realize

July 6, 2022
The promise of repairing bones and tendons with human-made materials

The promise of repairing bones and tendons with human-made materials

January 4, 2022
As viral infections skyrocket, masks are still a tried-and-true way to help keep yourself and others safe

As viral infections skyrocket, masks are still a tried-and-true way to help keep yourself and others safe

December 14, 2022
How regulatory agencies, not the courts, are imposing COVID-19 vaccine mandates

How regulatory agencies, not the courts, are imposing COVID-19 vaccine mandates

October 24, 2021
Heart disease risk from saturated fats may depend on what foods they come from – new research

Heart disease risk from saturated fats may depend on what foods they come from – new research

November 29, 2021
Late night eating may cause greater weight gain – new research points to why

Late night eating may cause greater weight gain – new research points to why

October 12, 2022

10 Things I Learned During My Body Transformation

October 12, 2021

7 Health Benefits of Sweet Potatoes

October 12, 2021
Nobel prize: how chilli peppers helped researchers uncover how humans feel pain

Nobel prize: how chilli peppers helped researchers uncover how humans feel pain

October 12, 2021
How air filters can make COVID wards safer for patients and staff

How air filters can make COVID wards safer for patients and staff

December 1, 2021
GPs don’t give useful weight-loss advice – new study

GPs don’t give useful weight-loss advice – new study

December 16, 2022
Four ways to avoid gaining weight over the festive period – but also why you shouldn’t fret about it too much

Four ways to avoid gaining weight over the festive period – but also why you shouldn’t fret about it too much

December 22, 2022
Five ways to avoid pain and injury when starting a new exercise regime

Five ways to avoid pain and injury when starting a new exercise regime

December 30, 2022
Why suicide prevention support is crucial for people with fetal alcohol spectrum disorder

Why suicide prevention support is crucial for people with fetal alcohol spectrum disorder

September 28, 2022
Too hot to handle: Climate considerations for youth sport during the hottest years on record

Too hot to handle: Climate considerations for youth sport during the hottest years on record

July 19, 2022
  • Home
  • Health & Wellness
  • Disclaimer

© 2020 DAILY HEALTH NEWS

  • Home
  • Health & Wellness
  • Disclaimer
    • Terms of Use
    • Privacy Policy
    • DMCA Notice

© 2020 DAILY HEALTH NEWS